Search results
Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
Zacks via Yahoo Finance· 6 days agoThe company expects its existing cash, cash equivalents and marketable securities, together with the...
Top 50 Companies Donate More Than $1.5 Billion and Engage Employees in 6.5 Million Hours of...
Morningstar· 1 day agoPoints of Light Civic 50 Program Honors Top Companies for Corporate Citizenship, Social Impact and Community EngagementNORTHAMPTON, MA / ACCESSWIRE / May 14, 2024 / Points of Light, a nonpartisan ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 12 hours agoU.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results expected during 1H’25 Strengthened leadership team with the appointment of Christopher J.
Meet the Mass. life science CEOs with the largest pay packages - Boston Business Journal
The Business Journals· 3 days agoHere's how much the 10 highest-paid CEOs of Massachusetts-based, publicly traded life science...
How Editas 'dragged' Linda Burkly over as CSO after 37 years at Biogen
FierceBiotech· 5 days agoLinda Burkly, Ph.D., was 37 years into a career at Biogen when Editas Medicines CEO Gilmore...
CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst
Guru Focus· 5 days agoRevenue: Reported at $504K, significantly below the estimated $26.55 million.Net Loss: Totaled $116.59 million, slightly above the estimated loss of $119.19 mi
Stock Market Moves Toward Highs: Weekly Review
Investor's Business Daily· 5 days agoBig earnings winners and losers continued.
Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
Zacks· 7 days agoFree Report) incurred a loss of 76 cents per share in the first quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 63 cents. The company had reported a loss of 71 cents per ...
